Visanu Thamlikitkul
2 Wang Lang Rd
Bangkok Noi, Thailand
Bangkok Noi, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Mapping the resistance landscape: A large-scale study of polymyxin-resistant pathogens circulating in low-and middle-income countries.
Journal: Research square
Published: August 20, 2026
International implementation of ASIARS-net for AMR surveillance: Building on JANIS.
Journal: Journal of global antimicrobial resistance
Published: February 18, 2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME Trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 12, 2026
A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 11, 2026
Access to new antibacterials in 10 Asian countries: An Asian network for surveillance of resistant pathogens study.
Journal: International journal of antimicrobial agents
Published: November 16, 2025
Cluster-Randomized Controlled Trial of Enhanced Carbapenem-Resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 13, 2025
In vitro activity of sulbactam in combination with other antimicrobial agents against extensively drug-resistant Acinetobacter baumannii.
Journal: Microbiology spectrum
Published: August 12, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial.
Journal: The Lancet. Infectious diseases
Published: May 20, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of People With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 02, 2025
Disposition of colistin in critically-ill patients on sustained low-efficiency dialysis: A population pharmacokinetic study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 10, 2025
Efficacy and Safety of Oral Neomycin for the Decolonization of Carbapenem-Resistant Enterobacterales: An Open-Label Randomized Controlled Trial.
Journal: Antibiotics (Basel, Switzerland)
Published: July 02, 2024
Convergence and global molecular epidemiology of Klebsiella pneumoniae plasmids harbouring the iuc3 virulence locus: a population genomic analysis.
Journal: The Lancet. Microbe
Published: February 20, 2024
Last Updated: 09/26/2026